INBX

$128.79-0.42 (-0.33%)

After Hours$127.79-1.00 (-0.78%)· Last close May 1

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO